CIK 0001515673
- Large accelerated filer
Ultragenyx Pharmaceutical Inc.
Sign in to watch- Ticker
- RARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272546083
- Phone
- +1 415-483-8800
- Business address
- 60 LEVERONI COURT, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $127,561
- in 3 filings, $17K under 10b5-1 plans
Net −$127,561. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-29 | Sanders Corazon (Corsee) D. Director | Grant or award | +3,895 | 3,895 | ||
| 2021-06-29 | Sanders Corazon (Corsee) D. Director | Grant or award · Stock Option (Right to Buy) | +7,255 | 7,255 | ||
| 2021-06-24 | WELCH DANIEL G Director | Grant or award | +2,145 | 14,445 | ||
| 2021-06-24 | WELCH DANIEL G Director | Grant or award · Stock Option (Right to Buy) | +4,125 | 4,125 | ||
| 2021-06-24 | Aliski William Director | Grant or award | +2,145 | 66,849 | ||
| 2021-06-24 | Aliski William Director | Grant or award · Stock Option (Right to Buy) | +4,125 | 4,125 | ||
| 2021-06-24 | Dunsire Deborah Director | Grant or award | +2,145 | 12,570 | ||
| 2021-06-24 | Dunsire Deborah Director | Grant or award · Stock Option (Right to Buy) | +4,125 | 4,125 | ||
| 2021-06-24 | Ekman Lars Director | Grant or award | +2,145 | 14,445 | ||
| 2021-06-24 | Ekman Lars Director | Grant or award · Stock Option (Right to Buy) | +4,125 | 4,125 | ||
| 2021-06-24 | Fust Matthew K Director | Grant or award | +2,145 | 15,695 | ||
| 2021-06-24 | Fust Matthew K Director | Grant or award · Stock Option (Right to Buy) | +4,125 | 4,125 | ||
| 2021-06-24 | NARACHI MICHAEL Director | Grant or award | +2,145 | 14,445 | ||
| 2021-06-24 | NARACHI MICHAEL Director | Grant or award · Stock Option (Right to Buy) | +4,125 | 4,125 | ||
| 2021-06-24 | SULIMAN SHEHNAAZ Director | Grant or award | +2,145 | 7,695 | ||
| 2021-06-24 | SULIMAN SHEHNAAZ Director | Grant or award · Stock Option (Right to Buy) | +4,125 | 4,125 | ||
| 2021-06-21 | Harris Erik EVP & Chief Commercial Officer | Sale | −572 | $94.96 | $54K | 25,708 |
| 2021-06-19 | Harris Erik EVP & Chief Commercial Officer | Sale | −437 | $94.63 | $41K | 26,280 |
| 2021-06-10 | Parschauer Karah Herdman EVP and General Counsel | Sale | −1,329 | $100.00 | $133K | 28,668 |
| 2021-05-07 | Harris Erik EVP & Chief Commercial Officer | Sale | −393 | $113.67 | $45K | 26,717 |
Page 19 of 21 · 410 trades